Topline A previous Covid infection provided more “durable” protection against infection with the omicron variant than two or three doses of Pfizer or Moderna’s vaccines—but protectio...
Tag: Pfizer
Moderna And Pfizer Covid Vaccines For Young Children Endorsed By FDA Panel
Topline A Food and Drug Administration advisory committee on Wednesday voted unanimously to recommend Pfizer-BioNTech and Moderna’s Covid-19 vaccines for young children, a step that could clear the wa...
Pfizer, Moderna Covid Vaccines Are Effective In Young Children, FDA Says—Here’s How They Differ And What Happens Next
Topline Three doses of Pfizer’s vaccine and a two-doses of Moderna’s shot are safe and effective in preventing illness from Covid-19 in young children, according to assessments provided by the Food an...
U.S. Stocks Poised to Open Lower on Monday Ahead of Fed Week
Stocks are poised to open lower on Monday. (Photo by Spencer Platt/Getty Images) Getty Images Text size U.S. stocks were poised for a lower opening on Monday ahead of the Federal Reserve’s decision on...
Cathie Wood’s Ark Invest Buys Moderna Stock After $100 Billion Crash—And Sells Rival Vaccine-Maker Pfizer
Topline New York City investment firm Ark Invest, helmed by high-profile stock picker Cathie Wood, offloaded a large chunk of top-holding Pfizer on Wednesday and poured into rival vaccine-maker Modern...
Novavax’s New Covid-19 Vaccine Might Be Late to the Party
It’s one thing to arrive fashionably late to a party, it’s another thing to waltz in when the last guests are stumbling out the door. For Novavax , which on Tuesday cleared a key step toward U.S. Food...
Turning Point Stock Doubles on Bristol Deal. What It Means for Biotech M&A.
Text size Photograph by Georges Gobet/AFP/Getty Images Turning Point Therapeutics stock has more than doubled after Bristol Myers Squibb announced that it had agreed to buy the company. It’s just the ...
Pfizer Asks FDA To Greenlight Covid Vaccine For Children Under 5
Topline Pfizer has asked the Food and Drug Administration to authorize its three-dose Covid-19 vaccine for children under 5, the company announced Wednesday evening, a move that could extend protectio...
GSK Stock: How It’s Spending Up To $3.3 Billion To Square Off With Pfizer, Merck
GlaxoSmithKline (GSK) is squaring off with Pfizer (PFE) and Merck (MRK) after announcing Tuesday a $3.3 billion deal to buy pneumonia vaccine-maker Affinivax. But GSK stock dipped at the close. X The ...
Pfizer Offers Low-Cost Drugs And Vaccines—Including Covid Treatments—To World’s Poorest Countries
Topline Pharmaceutical giant Pfizer on Wednesday said it will make its entire portfolio of patented medicines and vaccines available to low-income countries on a not-for-profit basis in a bid to narro...
Pfizer Says Three Shots Of Low-Dose Vaccine Generates ‘Strong Immune Response’ In Kids Under 5
Topline Pfizer and BioNTech on Monday said they will ask the Food and Drug Administration to authorize a three-shot regimen of their Covid-19 vaccine for children under five citing promising clinical ...
Stocks Are Ready for a Bounce Higher After S&P 500 Closes Above Bear Market
Text size Dreamstime The stock market came awfully close to finishing Friday in a bear market, at least 20% off its peak in early January. Many investors would like to see it get there so Wall Street ...
CDC Panel Recommends Approving Third Pfizer Covid Shot For Children 5 To 11
Topline A Centers for Disease Control and Prevention advisory board voted Thursday to recommend letting children ages 5 to 11 receive a third dose of Pfizer’s coronavirus vaccine shots, two days after...
CDC panel recommends Pfizer booster for children ages 5 to 11
The Centers for Disease Control and Prevention’s independent vaccine experts recommended a Pfizer Covid booster shot for children ages 5 to 11 on Thursday, as infections rise across the country ...
Pfizer’s Covid Vaccine Protection Against Omicron Fades Just Weeks After Second And Third Doses, Study Finds
Topline Immunity against the omicron coronavirus variant fades rapidly after a second and third dose of Pfizer and BioNTech’s Covid-19 vaccine, according to peer reviewed research published in JAMA Ne...
Pfizer Turns to Unusual Deal Structure to Buy Biohaven Drugs
(Bloomberg) — Pfizer Inc.’s $11.6 billion acquisition of Biohaven Pharmaceutical Holding Co. included a rarely used structure that could become a larger part of Big Pharma’s playbook in light of...
BioNTech Earnings Top Forecasts on Strong Sales of Covid-19 Vaccine
Text size BioNTech is continuing to work with Pfizer on follow-on Covid-19 vaccines. (Photo by THOMAS LOHNES/AFP via Getty Images) BioNTech , the German biotech company, reported first-quarter earning...
Big Pharma Has Enough Cash to Buy All of Biotech. Why M&A Isn’t Happening.
Text size Late last year, Barron’s predicted a wave of deals, citing biotech companies’ cash holdings. Above, the plates used to print one-dollar bills. Alex Wong/Getty Images With biotech...
FDA Limits Use Of Johnson & Johnson Vaccine Due To Blood Clot Risk
Topline Johnson & Johnson’s coronavirus vaccine is now only authorized for U.S. adults who are unable to receive other vaccines, the Food and Drug Administration announced Thursday, citing the Joh...
As Pfizer Faces a Period of Volatility, Here’s My Plan for the Shares
The numbers for Pfizer (PFE) are excellent. The guidance? Meh. Pfizer released the firm’s first quarter financial performance on Tuesday morning. Pfizer posted adjusted EPS of $1.62 (GAAP EPS of...
Pfizer revenue growth soars 77% as PFE beats earnings estimates by almost $1 billion
On May 3, Pfizer (NYSE: PFE) posted a blowout quarter, with revenue growth of 77% year-on-year (YoY) and earnings per share (EPS) growth of 70.53%. Further, the company reaffirmed its full-year 2022 f...
Pfizer Paxlovid prescriptions to treat Covid increased tenfold in U.S.
Pfizer on Tuesday said prescriptions for its oral antiviral to treat Covid-19 have increased nearly tenfold in the U.S. since late February, as more pharmacies and other locations receive supply. CEO ...
Pfizer lowers earnings guidance despite a solid Q1
Shares of Pfizer Inc (NYSE: PFE) are slightly up this morning after the pharmaceutical giant reported market-beating results for its fiscal Q1 on strong sales of its COVID treatments. Pfizer Q1 financ...
Covid Pfizer (PFE) earnings Q1 2022
Albert Bourla, chief executive officer of Pfizer pharmaceutical company, arrives to ring the closing bell at the New York Stock Exchange. Drew Angerer | Getty Images Pfizer on Tuesday slashed its 2022...
Novavax Gets a Sell Rating. It’s Got a Covid Vaccine Problem, Analyst Says.
Text size A healthcare worker prepares a dose of Nuvaxovid vaccine. Jeroen Jumelet/ANP/AFP via Getty Images Novavax stock was dropping Friday after receiving a Sell-equivalent rating — the first since...